1. Home
  2. ADGM vs CTXR Comparison

ADGM vs CTXR Comparison

Compare ADGM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADGM
  • CTXR
  • Stock Information
  • Founded
  • ADGM 2011
  • CTXR 2007
  • Country
  • ADGM United States
  • CTXR United States
  • Employees
  • ADGM N/A
  • CTXR N/A
  • Industry
  • ADGM
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADGM
  • CTXR Health Care
  • Exchange
  • ADGM NYSE
  • CTXR Nasdaq
  • Market Cap
  • ADGM 14.7M
  • CTXR 14.6M
  • IPO Year
  • ADGM N/A
  • CTXR N/A
  • Fundamental
  • Price
  • ADGM $0.79
  • CTXR $1.03
  • Analyst Decision
  • ADGM
  • CTXR Strong Buy
  • Analyst Count
  • ADGM 0
  • CTXR 2
  • Target Price
  • ADGM N/A
  • CTXR $54.50
  • AVG Volume (30 Days)
  • ADGM 39.6K
  • CTXR 613.8K
  • Earning Date
  • ADGM 03-31-2025
  • CTXR 05-13-2025
  • Dividend Yield
  • ADGM N/A
  • CTXR N/A
  • EPS Growth
  • ADGM N/A
  • CTXR N/A
  • EPS
  • ADGM N/A
  • CTXR N/A
  • Revenue
  • ADGM $602,000.00
  • CTXR N/A
  • Revenue This Year
  • ADGM N/A
  • CTXR N/A
  • Revenue Next Year
  • ADGM N/A
  • CTXR N/A
  • P/E Ratio
  • ADGM N/A
  • CTXR N/A
  • Revenue Growth
  • ADGM 100.67
  • CTXR N/A
  • 52 Week Low
  • ADGM $0.75
  • CTXR $0.99
  • 52 Week High
  • ADGM $9.34
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • ADGM N/A
  • CTXR 27.10
  • Support Level
  • ADGM N/A
  • CTXR $1.21
  • Resistance Level
  • ADGM N/A
  • CTXR $2.28
  • Average True Range (ATR)
  • ADGM 0.00
  • CTXR 0.21
  • MACD
  • ADGM 0.00
  • CTXR -0.00
  • Stochastic Oscillator
  • ADGM 0.00
  • CTXR 2.89

About ADGM ADAGIO MEDICAL HOLDINGS INC

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: